Literature DB >> 29502276

Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice.

Sara Faccidomo1, Katarina S Swaim1, Briana L Saunders1, Taruni S Santanam1, Seth M Taylor1, Michelle Kim1, Grant T Reid1, Vallari R Eastman1, Clyde W Hodge2,3.   

Abstract

RATIONALE: There is a clear need for discovery of effective medications to treat behavioral pathologies associated with alcohol addiction, such as chronic drinking.
OBJECTIVE: The goal of this preclinical study was to assess effects of chronic alcohol drinking on the nucleus accumbens (NAcb) proteome to identify and validate novel targets for medications development.
MATERIALS AND METHODS: Two-dimensional difference in-gel electrophoresis (2D-DIGE) with matrix-assisted laser desorption ionization tandem time-of-flight (MALDI-TOF/TOF) was used to assess effects of chronic voluntary home-cage (24-h access) alcohol drinking on the NAcb proteome of C57BL/6J mice. To extend these findings to a model of alcohol self-administration and reinforcement, we investigated potential regulation of the positive reinforcing effects of alcohol by the target protein glutathione S-transferase Pi 1 (GSTP1) using a pharmacological inhibition strategy in mice trained to self-administer alcohol or sucrose.
RESULTS: Expression of 52 unique proteins in the NAcb was changed by chronic alcohol drinking relative to water control (23 upregulated, 29 downregulated). Ingenuity Pathway Analysis showed that alcohol drinking altered an array of protein networks associated with neurological and psychological disorders, molecular and cellular functions, and physiological systems and development. DAVID functional annotation analysis identified 9 proteins (SNCA, GSTP1, PRDX3, PPP3R1, EIF5A, PHB, PEBP1/RKIP, GAPDH, AND SOD1) that were significantly overrepresented in a functional cluster that included the Gene Ontology categories "response to alcohol" and "aging." Immunoblots confirmed changes in Pebp1 (RKIP) and GSTP1 in NAcb with no change in amygdala or frontal cortex, suggesting anatomical specificity. Systemic inhibition of GSTP1 with Ezatiostat (0-30 mg/kg, i.p.) dose-dependently reduced the reinforcing effects of alcohol as measured by operant self-administration, in the absence of motor effects. Sucrose self-administration was also reduced but in a manner associated with nonspecific motor inhibition.
CONCLUSIONS: Protein expression profiling identified an array of proteins and networks in the NAcb, including GSTP1, that are novel molecular targets of chronic alcohol drinking. Pharmacological inhibition of GSTP1 significantly reduced the positive reinforcing effects of alcohol, which regulate repetitive use and abuse liability. The observation that this protein was both upregulated after chronic drinking and that its inhibition could modulate the reinforcing properties of alcohol suggests that it is a key target for alcohol-related pathologies. Proteomic strategies combined with specific preclinical models has potential to identify and validate novel targets of alcohol that may be useful in the medical management of alcohol addiction.

Entities:  

Keywords:  2D-DIGE; Addiction; Alcohol; Drinking; GSTP1; Neurogranin; Nucleus accumbens; Operant; Pharmacotherapy; Proteome; RKIP; Reinforcement; Reward; SNCA; Self-administration

Mesh:

Substances:

Year:  2018        PMID: 29502276      PMCID: PMC5949261          DOI: 10.1007/s00213-018-4870-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  60 in total

Review 1.  Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.

Authors:  H R Kranzler
Journal:  Alcohol Alcohol       Date:  2000 Nov-Dec       Impact factor: 2.826

Review 2.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

Review 3.  The role of α-synuclein in the pathophysiology of alcoholism.

Authors:  Paulina Janeczek; Joanne M Lewohl
Journal:  Neurochem Int       Date:  2013-06-18       Impact factor: 3.921

4.  Operant ethanol self-administration increases extracellular-signal regulated protein kinase (ERK) phosphorylation in reward-related brain regions: selective regulation of positive reinforcement in the prefrontal cortex of C57BL/6J mice.

Authors:  Sara Faccidomo; Michael C Salling; Christina Galunas; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2015-06-28       Impact factor: 4.530

5.  Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.

Authors:  Azra Raza; Naomi Galili; Scott Smith; John Godwin; Jeffrey Lancet; Magda Melchert; Marsha Jones; James G Keck; Lisa Meng; Gail L Brown; Alan List
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

6.  Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP.

Authors:  Jason P Schroeder; Marina Spanos; Jennie R Stevenson; Joyce Besheer; Michael Salling; Clyde W Hodge
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

7.  Cue-induced reinstatement of alcohol-seeking behavior is associated with increased CaMKII T286 phosphorylation in the reward pathway of mice.

Authors:  Michael C Salling; Christopher J Hodge; Kelly E Psilos; Vallari R Eastman; Sara P Faccidomo; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2017-10-31       Impact factor: 3.533

8.  BDNF-mediated regulation of ethanol consumption requires the activation of the MAP kinase pathway and protein synthesis.

Authors:  Jerome Jeanblanc; Marian L Logrip; Patricia H Janak; Dorit Ron
Journal:  Eur J Neurosci       Date:  2012-11-28       Impact factor: 3.386

Review 9.  What the alcohol doctor ordered from the neuroscientist: Theragnostic biomarkers for personalized treatments.

Authors:  Markus Heilig; Lorenzo Leggio
Journal:  Prog Brain Res       Date:  2015-10-27       Impact factor: 2.453

10.  Dephosphorylation of protein kinase C substrates, neurogranin, neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A.

Authors:  K Seki; H C Chen; K P Huang
Journal:  Arch Biochem Biophys       Date:  1995-02-01       Impact factor: 4.013

View more
  4 in total

Review 1.  Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.

Authors:  Jessica L Hoffman; Sara Faccidomo; Michelle Kim; Seth M Taylor; Abigail E Agoglia; Ashley M May; Evan N Smith; L C Wong; Clyde W Hodge
Journal:  Int Rev Neurobiol       Date:  2019-10-23       Impact factor: 3.230

2.  Mechanisms underlying microRNA-222-3p modulation of methamphetamine-induced conditioned place preference in the nucleus accumbens in mice.

Authors:  Qing Shang; Jing Wang; Zhijia Xi; Baoyao Gao; Hongyan Qian; Ran An; Gaojie Shao; Hua Liu; Tao Li; Xinshe Liu
Journal:  Psychopharmacology (Berl)       Date:  2022-07-26       Impact factor: 4.415

3.  Inhibition of AMPA receptors (AMPARs) containing transmembrane AMPAR regulatory protein γ-8 with JNJ-55511118 shows preclinical efficacy in reducing chronic repetitive alcohol self-administration.

Authors:  Jessica L Hoffman; Sara Faccidomo; Briana L Saunders; Seth M Taylor; Michelle Kim; Clyde W Hodge
Journal:  Alcohol Clin Exp Res       Date:  2021-06-22       Impact factor: 3.455

4.  Pharmacological inhibition of glycogen synthase kinase 3 increases operant alcohol self-administration in a manner associated with altered pGSK-3β, protein interacting with C kinase and GluA2 protein expression in the reward pathway of male C57BL/6J mice.

Authors:  Sara Faccidomo; Sarah E Holstein; Taruni S Santanam; Briana L Saunders; Katarina S Swaim; Grant T Reid; Conor O'Neill; Vallari R Eastman; Clyde W Hodge
Journal:  Behav Pharmacol       Date:  2020-02       Impact factor: 2.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.